Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival

Journal of Clinical Oncology

Volumn 28, Issue 14, 2010, Pages 2467-2474

  Liu, Yanhong ^a   Shete, Sanjay ^a   Etzel, Carol J ^a   Scheurer, Michael ^a   Alexiou, George ^a   Armstrong, Georgina ^a   Tsavachidis, Spyros ^a   Liang, Fu Wen ^a   Gilbert, Mark ^a   Aldape, Ken ^a   Armstrong, Terri ^a   Houlston, Richard ^a   Hosking, Fay ^a   Robertson, Lindsay ^a   Xiao, Yuanyuan ^a   Wiencke, John ^a   Wrensch, Margaret ^a   Andersson, Ulrika ^a   Melin, Beatrice S ^a   Bondy, Melissa ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; DNA REPAIR; FEMALE; GENE BTBD2; GENE HMGA2; GENE LIG4; GENE RTEL1; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PRIORITY JOURNAL; SURVIVAL TIME; AGE; BRAIN TUMOR; CHI SQUARE DISTRIBUTION; DECISION TREE; DOUBLE STRANDED DNA BREAK; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RISK; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVOR; TIME; TREATMENT OUTCOME;

BTBD2 PROTEIN, HUMAN; CARRIER PROTEIN; HELICASE; HIGH MOBILITY GROUP A2 PROTEIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE (ATP); RTEL1 PROTEIN, HUMAN;

AGE FACTORS; BRAIN NEOPLASMS; CARRIER PROTEINS; CHI-SQUARE DISTRIBUTION; DECISION TREES; DNA BREAKS, DOUBLE-STRANDED; DNA HELICASES; DNA LIGASES; DNA REPAIR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GLIOBLASTOMA; HMGA2 PROTEIN; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77952525364     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.26.6213     Document Type: Article

References (46)

1. Holland EC: Glioblastoma multiforme: The terminator. Proc Natl Acad Sci U S A 97:6242-6244, 2000
2. Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005 (Pubitemid 40349501)
3. Scott JN, Rewcastle NB, Brasher PM, et al: Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol 46:183-188, 1999 (Pubitemid 29382874)
4. Curran WJ Jr, Scott CB, Horton J, et al: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704-710, 1993 (Pubitemid 23133591)
5. Lacroix M, Abi-Said D, Fourney DR, et al: A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, extent of resection, and survival. J Neurosurg 95:190-198, 2001 (Pubitemid 32799739)
6. Colman H, Aldape K: Molecular predictors in glioblastoma: Toward personalized therapy. Arch Neurol 65:877-883, 2008 (Pubitemid 352008470)
7. Martinez R, Schackert G, Yaya-Tur R, et al: Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme. J Neurooncol 83:91-93, 2007 (Pubitemid 46647170)
8. Krex D, Klink B, Hartmann C, et al: Long-term survival with glioblastoma multiforme. Brain 130:2596-2606, 2007 (Pubitemid 47511715)
9. Cancer Genome Atlas Research Network: Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061-1068, 2008
10. Parsons DW, Jones S, Zhang X, et al: An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807-1812, 2008
11. Bredel M, Scholtens DM, Harsh GR, et al: A network model of a cooperative genetic landscape in brain tumors. JAMA 302:261-275, 2009
12. Wang L, Wei Q, Wang LE, et al: Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. J Clin Oncol 24:1627-1632, 2006 (Pubitemid 46638787)
13. Scheurer ME, Amirian E, Cao Y, et al: Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma. Clin Cancer Res 14:6640-6646, 2008
14. Bhowmick DA, Zhuang Z, Wait SD, et al: A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res 64:1220-1223, 2004 (Pubitemid 38235584)
15. Vauleon E, Auger N, Benouaich-Amiel A, et al: The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma. Cancer Genet Cytogenet 172:33-37, 2007 (Pubitemid 44920265)
16. Rodero M, Marie Y, Coudert M, et al: Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma. J Clin Oncol 26:5957-5964, 2008
17. Shete S, Hosking FJ, Robertson LB, et al: Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41:899-904, 2009
18. Wrensch M, Jenkins RB, Chang JS, et al: Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41:905-908, 2009
19. Liu Y, Scheurer ME, El-Zein R, et al: Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev 18:204-214, 2009
20. Wacholder S, Chanock S, Garcia-Closas M, et al: Assessing the probability that a positive report is false: An approach for molecular epidemiology studies. J Natl Cancer Inst 96:434-442, 2004 (Pubitemid 38443646)
21. Wakefield J: A Bayesian measure of the probability of false discovery in genetic epidemiology studies. Am J Hum Genet 81:208-227, 2007
22. Therneau T, Atkinson B: Technical Report Series No. 61, An Introduction to Recursive Partitioning Using the RPART Routines. Rochester, MN, Department of Health Science Research, Mayo Clinic, 1997
23. Chang SM, Parney IF, Huang W, et al: Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293:557-564, 2005 (Pubitemid 40171237)
24. Central Brain Tumor Registry of the United States: SEER: Statistical report: Primary brain tumors in the United States, 2000-2004. Chicago, IL, Central Brain Tumor Registry of the United States, 2008
25. Liu Y, Zhou K, Zhang H, et al: Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma. Hum Mutat 29:381-389, 2008 (Pubitemid 351364940)
26. Roddam PL, Rollinson S, O'Driscoll M, et al: Genetic variants of NHEJ DNA ligase IV can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class switch recombination. J Med Genet 39:900-905, 2002 (Pubitemid 36009151)
27. Goode EL, Dunning AM, Kuschel B, et al: Effect of germ-line genetic variation on breast cancer survival in a population-based study. Cancer Res 62:3052-3057, 2002 (Pubitemid 34602394)
28. Xu L, Yang L, Hashimoto K, et al: Characterization of BTBD1 and BTBD2, two similar BTB-domain-containing Kelch-like proteins that interact with Topoisomerase I. BMC Genomics 3:1, 2002
29. Champoux JJ: DNA topoisomerases: Structure, function, and mechanism. Annu Rev Biochem 70:369-413, 2001
30. Wang JC: Cellular roles of DNA topoisomerases: A molecular perspective. Nat Rev Mol Cell Biol 3:430-440, 2002
31. Bredel M, Piribauer M, Marosi C, et al: High expression of DNA topoisomerase IIalpha and Ki-67 antigen is associated with prolonged survival in glioblastoma patients. Eur J Cancer 38:1343-1347, 2002 (Pubitemid 34686844)
32. Yin W, Rossin A, Clifford JL, et al: Coresistance to retinoic acid and TRAIL by insertion mutagenesis into RAM. Oncogene 25:3735-3744, 2006 (Pubitemid 43980494)
33. Jiang M, Zhu K, Grenet J, et al: Retinoic acid induces caspase-8 transcription via phospho-CREB and increases apoptotic responses to death stimuli in neuroblastoma cells. Biochim Biophys Acta 1783:1055-1067, 2008
34. Das A, Banik NL, Ray SK: Differentiation decreased telomerase activity in rat glioblastoma C6 cells and increased sensitivity to IFN-gamma and taxol for apoptosis. Neurochem Res 32:2167-2183, 2007 (Pubitemid 350059861)
35. Li AY, Boo LM, Wang SY, et al: Suppression of nonhomologous end joining repair by overexpression of HMGA2. Cancer Res 69:5699-5706, 2009
36. Cleynen I, Van de Ven WJ: The HMGA proteins: A myriad of functions (Review). Int J Oncol 32:289-305, 2008 (Pubitemid 351188295)
37. Barber LJ, Youds JL, Ward JD, et al: RTEL1 maintains genomic stability by suppressing homologous recombination. Cell 135:261-271, 2008
38. Little MP, De Vathaire F, Shamsaldin A, et al: Risks of brain tumour following treatment for cancer in childhood: Modification by genetic factors, radiotherapy and chemotherapy. Inter J Cancer 78:269-275, 1998 (Pubitemid 28445359)
39. Bondy ML, Wang LE, El-Zein R, et al: Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst 93:1553-1557, 2001
40. Neglia JP, Robison LL, Stovall M, et al: New primary neoplasms of the central nervous system in survivors of childhood cancer: A report from the childhood cancer survivor study. J Natl Cancer Inst 98:1528-1537, 2006 (Pubitemid 44680904)
41. Mueller JC, Lohmussaar E, Magi R, et al: Linkage disequilibrium patterns and tagSNP transferability among European populations. Am J Hum Genet 76:387-398, 2005 (Pubitemid 40250519)
42. Lundmark PE, Liljedahl U, Boomsma DI, et al: Evaluation of HapMap data in six populations of European descent. Eur J Hum Genet 16:1142-1150, 2008
43. Morgan TM, Krumholz HM, Lifton RP, et al: Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA 297:1551-1561, 2007 (Pubitemid 46588368)
44. Gorroochurn P, Hodge SE, Heiman GA, et al: Non-replication of association studies: "pseudofailures" to replicate? Genet Med 9:325-331, 2007
45. Clarke GM, Carter KW, Palmer LJ, et al: Fine mapping versus replication in whole-genome association studies. Am J Hum Genet 81:995-1005, 2007 (Pubitemid 47580252)
46. Liu YJ, Papasian CJ, Liu JF, et al: Is replication the gold standard for validating genome-wide association findings? PLoS One 3:e4037, 2008